Söding, J.: Proposed mechanism for thrombotic thrombocytopenia induced by adenovirus-based COVID-19 vaccines. (2021), 4 pp.

Söding, J.: The immune activation model for targeted inhibitors of mutated oncogenic kinases. (2021)

Stark, H.; Leppanen, J. M.; Sasse, B. C.; Saur, O.; Kottke, T.; Michael, P.: Medicaments. US 08389555 (2013)

Tkach, I.; Bennati, M.: Dual-mode microwave resonator device and method of electron spin resonance measurement. EP 2486416 B1 (2013)

Raga, M.; Sallares, J.; Guerrero, M.; Guglietta, A.; Arrang, J. M.; Schwartz, J. C.; Stark, H.; Schunack, W.; Ligneau, X.; Lecomte, J. M. et al.; Ganellin, C.: Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine. US 08354430 (2013)

Zweckstetter, M.; Karpinar, P.; Griesinger, C.: Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)

Giese, A.; Bertsch, U.; Kretzschmar, H.; Habeck, M.; Hirschberger, T.; Tavan, P.; Griesinger, C.; Leonov, A.; Ryazanov, S.; Weber, P.: New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)

Nagy, G.; Grubmüller, H.: How accurate are circular dichroism based secondary structure estimates? (2020)